An estimated 25 per cent of R&D budgets are now being spent on externalisation, it is crucial to develop strategic and effective business models and determine how best to outsource the different processes of drug discovery.
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
Pharma Contract Manufacturing
23 - 25 March 2026
Mercure Hotel MOA Berlin, Germany
Register Now |
View Agenda |
Learn More